Precision Medical Group, backed by Berkshire Partners, TPG Growth, awaits first round bids
Precision Medical Group, which helps pharma and life science companies develop and bring new products to market, is up for sale, according to multiple sources familiar with the matter.
Goldman Sachs is advising on the process, with first round bids for the private equity-backed company scheduled for August 24, the people said.
A narrow group of large buyout funds and one strategic are expected to bid, one of the people said.
Precision is marketing adjusted EBITDA of $1...